What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Anthony J. Gill focuses on Pathology, Internal medicine, Cancer research, Pancreatic cancer and Germline mutation.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology.
The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Cancer, MLH1, Mutation and MSH2.
His Mutation study introduces a deeper knowledge of Genetics.
Anthony J. Gill has researched Pancreatic cancer in several fields, including Clinical trial, Bioinformatics, Surgery, KRAS and CDKN2A.
His research integrates issues of Point mutation and Germline in his study of Germline mutation.
His most cited work include:
- Genomic analyses identify molecular subtypes of pancreatic cancer (1396 citations)
- Genomic analyses identify molecular subtypes of pancreatic cancer (1396 citations)
- Whole genomes redefine the mutational landscape of pancreatic cancer. (1318 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Pathology, Internal medicine, Immunohistochemistry, Cancer research and Oncology.
The Pathology study combines topics in areas such as Germline mutation and SDHB.
His Internal medicine research incorporates elements of Gastroenterology and Endocrinology.
Anthony J. Gill interconnects Carcinogenesis, Cancer and Mutation in the investigation of issues within Cancer research.
His biological study deals with issues like Colorectal cancer, which deal with fields such as Microsatellite instability.
His studies in Pancreatic cancer integrate themes in fields like Neoadjuvant therapy and Surgery.
He most often published in these fields:
- Pathology (65.75%)
- Internal medicine (55.37%)
- Immunohistochemistry (42.72%)
What were the highlights of his more recent work (between 2019-2021)?
- Pathology (65.75%)
- Internal medicine (55.37%)
- Cancer research (35.92%)
In recent papers he was focusing on the following fields of study:
Anthony J. Gill spends much of his time researching Pathology, Internal medicine, Cancer research, Oncology and Immunohistochemistry.
As part of one scientific family, Anthony J. Gill deals mainly with the area of Pathology, narrowing it down to issues related to the Targeted therapy, and often Mutation.
He studied Internal medicine and Gastroenterology that intersect with Pancreas.
His research in Cancer research tackles topics such as Carcinogenesis which are related to areas like Dysplasia.
Anthony J. Gill focuses mostly in the field of Immunohistochemistry, narrowing it down to topics relating to Disease and, in certain cases, Parathyroid gland and Surgical pathology.
His Pancreatic cancer research includes elements of Neoadjuvant therapy and Surgery.
Between 2019 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases. (19 citations)
- Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer (17 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His main research concerns Pathology, Immunohistochemistry, Sarcoma, Internal medicine and Pancreatic cancer.
His biological study spans a wide range of topics, including Targeted therapy and Multiple endocrine neoplasia type 2.
His Immunohistochemistry study incorporates themes from Staining, Antibody, Succinate dehydrogenase and Cancer research.
His Cancer research study combines topics in areas such as Carcinogenesis, Locally advanced, Dysplasia and Intraepithelial neoplasia.
Anthony J. Gill has included themes like Gastroenterology and Oncology in his Internal medicine study.
His work deals with themes such as Neoadjuvant therapy, Biomarker, Exome, Pancreatic cysts and Gene dosage, which intersect with Pancreatic cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
